Michael S. O’Reilly

16.3k total citations · 5 hit papers
79 papers, 12.0k citations indexed

About

Michael S. O’Reilly is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael S. O’Reilly has authored 79 papers receiving a total of 12.0k indexed citations (citations by other indexed papers that have themselves been cited), including 41 papers in Molecular Biology, 34 papers in Cancer Research and 32 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael S. O’Reilly's work include Angiogenesis and VEGF in Cancer (31 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer, Hypoxia, and Metabolism (23 papers). Michael S. O’Reilly is often cited by papers focused on Angiogenesis and VEGF in Cancer (31 papers), Lung Cancer Treatments and Mutations (24 papers) and Cancer, Hypoxia, and Metabolism (23 papers). Michael S. O’Reilly collaborates with scholars based in United States, China and United Kingdom. Michael S. O’Reilly's co-authors include Judah Folkman, Lars Holmgren, Thomas Boehm, Judah Folkman, Yuen Shing, Naomi Fukai, William S. Lane, Evelyn Flynn, Bjørn R. Olsen and George Vasios and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Michael S. O’Reilly

78 papers receiving 11.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth

1997 3.7k citations Michael S. O’Reilly, Judah Folkman et al. profile →
Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression

1995 1.5k citations Michael S. O’Reilly et al. profile →
Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

1997 1.4k citations Judah Folkman, Michael S. O’Reilly et al. profile →
Angiostatin induces and sustains dormancy of human primary tumors in mice

1996 975 citations Michael S. O’Reilly, Judah Folkman et al. profile →
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non–Small-Cell Lung Cancer

2018 214 citations Zhongxing Liao, Ritsuko Komaki et al. profile →

Peers

Countries citing papers authored by Michael S. O’Reilly

Since Specialization

Citations

This map shows the geographic impact of Michael S. O’Reilly's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael S. O’Reilly with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael S. O’Reilly more than expected).

Fields of papers citing papers by Michael S. O’Reilly

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael S. O’Reilly. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael S. O’Reilly. The network helps show where Michael S. O’Reilly may publish in the future.

Co-authorship network of co-authors of Michael S. O’Reilly

This figure shows the co-authorship network connecting the top 25 collaborators of Michael S. O’Reilly. A scholar is included among the top collaborators of Michael S. O’Reilly based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael S. O’Reilly. Michael S. O’Reilly is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Salvage Reirradiation with Proton Beam Therapy for Locoregionally Recurrent Non-Small Cell Lung Cancer 2024 ·Cancers ·Matthew S. Ning, (unknown), Joe Y. Chang, Saumil Gandhi, Zhongxing Liao, Steven H. Lin, Aileen B. Chen, James W. Welsh, Quynh‐Nhu Nguyen, Michael S. O’Reilly, Stephen G. Chun, Julianna Bronk, David C. Qian, Percy Lee	2
2	Generalizability of Deep Learning Classification of Spinal Osteoporotic Compression Fractures on Radiographs Using an Adaptation of the Modified-2 Algorithm-Based Qualitative Criteria 2023 ·Academic Radiology ·(unknown), Gang Luo, Nancy E. Lane, Li‐Yung Lui, Lynn M. Marshall, Sandra K. Johnston, (unknown), Michael S. O’Reilly, Ken F. Linnau, (unknown), (unknown), (unknown), David R. Haynor, Jeffrey G. Jarvik, Nathan Cross	11
3	Rapid Detection of Asymptomatic Coronavirus Disease 2019 by Computed Tomography Image Guidance for Stereotactic Ablative Radiotherapy 2020 ·Journal of Thoracic Oncology ·Gwendolyn J. McGinnis, Matthew S. Ning, P Nitsch, Michael S. O’Reilly, Mary Frances McAleer, Albert C. Koong, Joe Y. Chang	10
4	Long-term outcome of phase I/II prospective study of dose-escalated proton therapy for early-stage non-small cell lung cancer 2017 ·Radiotherapy and Oncology ·Joe Y. Chang, Wencheng Zhang, Ritsuko Komaki, Noah C. Choi, (unknown), Daniel R. Gomez, Michael S. O’Reilly, Melenda Jeter, Michael T. Gillin, Xiaorong Zhu, Xiaodong Zhang, Radhe Mohan, Stephen G. Swisher, Stephen M. Hahn, James D. Cox	28
5	Long-Term Outcomes of Salvage Stereotactic Ablative Radiotherapy for Isolated Lung Recurrence of Non–Small Cell Lung Cancer: A Phase II Clinical Trial 2017 ·Journal of Thoracic Oncology ·Bing Sun, Eric D. Brooks, Ritsuko Komaki, Zhongxing Liao, Melenda Jeter, Mary Frances McAleer, Peter Balter, James Welsh, Michael S. O’Reilly, Daniel R. Gomez, Stephen M. Hahn, Boris Sepesi, David C. Rice, John V. Heymach, Joe Y. Chang	52
6	Simultaneous Integrated Boost for Radiation Dose Escalation to the Gross Tumor Volume With Intensity Modulated (Photon) Radiation Therapy or Intensity Modulated Proton Therapy and Concurrent Chemotherapy for Stage II to III Non-Small Cell Lung Cancer: A Phase 1 Study 2017 ·International Journal of Radiation OncologyBiologyPhysics ·Melenda Jeter, Daniel R. Gomez, Quynh-Nhu Nguyen, Ritsuko Komaki, Xiaodong Zhang, Xiaorong Zhu, Michael S. O’Reilly, Frank V. Fossella, Ting Xu, Wei Xiong, Hui Wang, Wenjuan Yang, Anne S. Tsao, Radhe Mohan, Zhongxing Liao	24
7	Prospective Study of Patient-Reported Symptom Burden in Patients With Non–Small-Cell Lung Cancer Undergoing Proton or Photon Chemoradiation Therapy 2016 ·Journal of Pain and Symptom Management ·Xin Shelley Wang, Qiuling Shi, Loretta A. Williams, Ritsuko Komaki, Daniel R. Gomez, Steven H. Lin, Joe Y. Chang, Michael S. O’Reilly, (unknown), James D. Cox, Radhe Mohan, Charles S. Cleeland, Zhongxing Liao	24
8	Evaluation of Novel Orthotopic Nude Mouse Models for Human Small-Cell Lung Cancer 2013 ·Journal of Thoracic Oncology ·Takeshi Isobe, Amir Onn, Daniel Morgensztern, Jörg J. Jacoby, Wenjuan Wu, Tomoaki Shintani, Satoshi Itasaka, Keiko Shibuya, (unknown), Michael S. O’Reilly, Roy S. Herbst	26
9	Do Angiotensin-Converting Enzyme Inhibitors Reduce the Risk of Symptomatic Radiation Pneumonitis in Patients With Non-Small Cell Lung Cancer After Definitive Radiation Therapy? Analysis of a Single-Institution Database 2013 ·International Journal of Radiation OncologyBiologyPhysics ·Hongmei Wang, Zhongxing Liao, Yan Zhuang, Ting Xu, Quynh-Nhu Nguyen, Lawrence B. Levy, Michael S. O’Reilly, Kathryn A. Gold, Daniel R. Gomez	30
10	Comparison of 2 Common Radiation Therapy Techniques for Definitive Treatment of Small Cell Lung Cancer 2013 ·International Journal of Radiation OncologyBiologyPhysics ·Shervin M. Shirvani, Aditya Juloori, Pamela K. Allen, Ritsuko Komaki, Zhongxing Liao, Daniel R. Gomez, Michael S. O’Reilly, James W. Welsh, Vassiliki A. Papadimitrakopoulou, James D. Cox, Joe Y. Chang	29
11	Prognostic Value of Positron Emission Tomography/Computed Tomography Findings in Limited-stage Small Cell Lung Cancer Before Chemoradiation Therapy 2012 ·American Journal of Clinical Oncology ·Daniel R. Gomez, Gregory W. Gladish, Wei Xiong, (unknown), Pamela K. Allen, James D. Cox, Michael S. O’Reilly, Jeremy J. Erasmus, Frank V. Fossella, Ritsuko Komaki	13
12	Genetic variants of the nonhomologous end joining gene LIG4 and severe radiation pneumonitis in nonsmall cell lung cancer patients treated with definitive radiotherapy 2011 ·Cancer ·Ming Yin, Zhongxing Liao, Zhensheng Liu, Li‐E Wang, Michael S. O’Reilly, Daniel R. Gomez, Minghuan Li, Ritsuko Komaki, Qingyi Wei	68
13	Treatment with HIF-1α Antagonist PX-478 Inhibits Progression and Spread of Orthotopic Human Small Cell Lung Cancer and Lung Adenocarcinoma in Mice 2010 ·Journal of Thoracic Oncology ·Jörg J. Jacoby, Baruch Erez, (unknown), Ryan Williams, Kazuhisa Furutani, Osamu Takahashi, Lynn Kirkpatrick, Scott M. Lippman, Garth Powis, Michael S. O’Reilly, Roy S. Herbst	67
14	Is sex associated with the outcome of patients treated with radiation for nonsmall cell lung cancer? 2009 ·Cancer ·Susan L. McGovern, Zhongxing Liao, M. Kara Bucci, Mary Frances McAleer, Melenda Jeter, Joe Y. Chang, Michael S. O’Reilly, James D. Cox, Pamela K. Allen, Ritsuko Komaki	16
15	Antiangiogenesis and Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Targeting as Part of a Combined-Modality Approach to the Treatment of Cancer 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Michael S. O’Reilly	19
16	Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice 2007 ·International Journal of Radiation OncologyBiologyPhysics ·Satoshi Itasaka, Ritsuko Komaki, Roy S. Herbst, Keiko Shibuya, Tomoaki Shintani, Nancy Hunter, Amir Onn, Corazon D. Bucana, Luka Milas, K. Kian Ang, Michael S. O’Reilly	41
17	ZD6474, a small molecule targeting VEGF and EGF receptor signaling, inhibits lung angiogenesis and metastasis and improves survival in an orthotopic model of non-small cell lung cancer 2004 ·Cancer Research ·Wenjuan Wu, Takeshi Isobe, Satoshi Itasaka, Tomoaki Shintani, Robert R. Langley, Amir Onn, (unknown), Michael S. O’Reilly, Roy S. Herbst	12
18	Direct effects of recombinant human endostatin on tumor cell IL-8 production are associated with increased endothelial cell apoptosis in an orthotopic model of human pancreatic cancer 2004 ·Cancer Biology & Therapy ·Chandrajit P. Raut, (unknown), Darren W. Davis, (unknown), Michael S. O’Reilly, David J. McConkey	69
19	Regulation of Angiostatin Mobilization by Tumor-Derived Matrix Metalloproteinase-2 2003 ·Lung Cancer ·Marsha A. Moses, Michael S. O’Reilly	2
20	Kringle Domains of Human Angiostatin 1996 ·Journal of Biological Chemistry ·Yihai Cao, (unknown), Donald J. Davidson, Johann Schaller, Daniel Martí, (unknown), Stephen G. McCance, Michael S. O’Reilly, Miguel Llinás, Judah Folkman	307

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact